Intervention for Hip Fracture
This trial will compare the effects of tranexamic acid (TXA) versus placebo on blood loss and transfusion requirements in patients over 60 years old who have undergone hip fracture surgery.
- Hip Fracture
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA given the go-ahead to this new method/drug/etc.?
"There is some evidence that the intervention being tested is effective, as well as numerous reports confirming its safety, so our team has given it a score of 3."
What is the typical reason why a doctor would prescribe Intervention?
"Although hyperfibrinolysis is the primary use case, Intervention is also effective for treating other conditions like hemophilia, bleeding, and tooth extractions."
Are new volunteers being sought for this experiment?
"The clinicaltrials.gov website indicates that this trial is not presently looking for participants. This particular trial was first posted on February 1st, 2020 and was last updated on October 25th, 2022. There are 455 other trials that are actively recruiting patients."
Is Intervention a common medical procedure?
"At the moment, 69 clinical trials studying Intervention are ongoing. Among these, 29 are in Phase 3. Many of the studies for Intervention are based in Kansas City, Kansas; however, 305 locations across the globe are running trials for this treatment."